This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer (PIE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Amgen
Novartis
Information provided by (Responsible Party):
Amanda Townsend, The Queen Elizabeth Hospital
ClinicalTrials.gov Identifier:
NCT01139138
First received: May 28, 2010
Last updated: February 8, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)